Robalzotan
Code | Size | Price |
---|
TAR-T24721-5mg | 5mg | £1,091.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24721-50mg | 50mg | £2,143.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T24721-100mg | 100mg | £2,801.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Robalzotan is a selective 5-HT1A receptor antagonist.
CAS:
169758-66-1
Formula:
C18H23FN2O2
Molecular Weight:
318.392
Purity:
0.98
SMILES:
NC(=O)c1ccc(F)c2OC[C@@H](Cc12)N(C1CCC1)C1CCC1
References
1. Pittal? V, Siracusa MA, Salerno L, Romeo G, Modica MN, Madjid N, Ogren SO. Analysis of mechanisms for memory enhancement using novel and potent 5-HT1A receptor ligands. Eur Neuropsychopharmacol. 2015 Aug;25(8):1314-23. doi: 10.1016/j.euroneuro.2015.04.017. Epub 2015 Apr 29. PubMed PMID: 25963581.
2. Brenna E, Gatti FG, Malpezzi L, Monti D, Parmeggiani F, Sacchetti A. Synthesis of robalzotan, ebalzotan, and rotigotine precursors via the stereoselective multienzymatic cascade reduction of ?,?-unsaturated aldehydes. J Org Chem. 2013 May 17;78(10):4811-22. doi: 10.1021/jo4003097. Epub 2013 May 8. PubMed PMID: 23611252.
3. Eriksson TM, Delagrange P, Spedding M, Popoli M, Math? AA, ?gren SO, Svenningsson P. Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration. Mol Psychiatry. 2012 Feb;17(2):173-84. doi: 10.1038/mp.2010.131. Epub 2011 Jan 18. PubMed PMID: 21242991; PubMed Central PMCID: PMC3265836.
4. Kehr J, Hu XJ, Yoshitake T, Wang FH, Osborne P, Stenfors C, Ogren SO. The selective 5-HT(1A) receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat. Eur Neuropsychopharmacol. 2010 Jul;20(7):487-500. doi: 10.1016/j.euroneuro.2010.03.003. Epub 2010 Apr 21. PubMed PMID: 20413275.